Fund Holdings — Casdin Capital, LLC

Total Portfolio Value
$1.20B
Total Bought
$142.86M
Total Sold
$152.18M
Net Transaction
-$9.33M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
AVIDITY BIOSCIENCES INC1,775,0001,780,000+5,00050,41077,5556.47%+27,145
TEMPUS AI INC(TEM)0294,127+294,127023,7391.98%+23,739
RELAY THERAPEUTICS INC(RLAY)11,398,57411,341,381-57,19339,43959,2024.94%+19,763
STRUCTURE THERAPEUTICS INC1,225,0001,555,000+330,00025,40743,5403.63%+18,134
REVOLUTION MEDICINES INC(RVMD)2,887,9332,647,333-240,600106,247123,63010.31%+17,383
ARS PHARMACEUTICALS INC(SPRY)01,600,000+1,600,000016,0801.34%+16,080
BEAM THERAPEUTICS INC(BEAM)1,450,0001,600,000+150,00024,66538,8323.24%+14,168
PRIME MEDICINE INC(PRME)1,567,1753,167,175+1,600,0003,87117,5461.46%+13,675
MAZE THERAPEUTICS INC(MAZE)758,857758,85709,31119,6771.64%+10,366
STANDARD BIOTOOLS INC(LAB)76,075,63677,558,856+1,483,22091,291100,8278.41%+9,536
UNITEDHEALTH GROUP INC(UNH)025,000+25,00008,6330.72%+8,633
INCYTE CORP(INCY)0100,000+100,00008,4810.71%+8,481
BIOLIFE SOLUTIONS INC(BLFS)7,707,1656,707,165-1,000,000166,012171,10014.27%+5,087
SEPTERNA INC(SEPN)553,268553,26805,84810,4070.87%+4,559
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)0282,312+282,31203,2690.27%+3,269
NEUROGENE INC(NGNE)1,295,3611,295,361019,36622,4491.87%+3,083
VERACYTE INC(VCYT)276,308276,30807,4699,4860.79%+2,017
HIMS & HERS HEALTH INC(HIMS)230,000230,000011,46613,0461.09%+1,580
CONTINEUM THERAPEUTICS INC(CTNM)148,333148,33305891,7430.15%+1,154
GUARDANT HEALTH INC(GH)100,000100,00005,2046,2480.52%+1,044
DENALI THERAPEUTICS INC(DNLI)890,000890,000012,45112,9231.08%+472
ABSCI CORPORATION973,260973,26002,5012,9590.25%+457
TENAYA THERAPEUTICS INC(TNYA)361,969361,96902215860.05%+365
MONTE ROSA THERAPEUTICS INC(GLUE)86,01486,01403886370.05%+249
GENEDX HOLDINGS CORP(WGS)3,507,1643,007,164-500,000323,746323,99227.01%+246
EXACT SCIENCES CORP(EXK)90,00090,00004,7834,9240.41%+141
GINKGO BIOWORKS HOLDINGS INC(DNA)36,49336,49304115320.04%+122
PACIFIC BIOSCIENCES CALIF IN(PACB)723,767723,76708979260.08%+29
RECURSION PHARMACEUTICALS IN(RXRX)165,323165,32308378070.07%-30
CENTURY THERAPEUTICS INC(IPSC)1,228,1901,228,19006866120.05%-75
ALNYLAM PHARMACEUTICALS INC(ALNY)81,50055,000-26,50026,57625,0802.09%-1,496
AGIOS PHARMACEUTICALS INC(AGIO)100,0000-100,0003,3260—-3,326
SYNDAX PHARMACEUTICALS INC(SNDX)650,0000-650,0006,0840—-6,084
ELI LILLY & CO(LLY)8,5000-8,5006,6260—-6,626
ILLUMINA INC(ILMN)645,000525,000-120,00061,53949,8594.16%-11,680
SAREPTA THERAPEUTICS INC(SRPT)990,0970-990,09716,9310—-16,931
CODEXIS INC(CDXS)7,200,0000-7,200,00017,5680—-17,568
VERVE THERAPEUTICS INC4,095,5710-4,095,57145,9930—-45,993
Page 1 of 1
Casdin Capital, LLC — 13F Holdings — Q3 2025 | TickerTrail